Search Results - "CICERI, Paola"

Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins by Ciceri, Paola, Cozzolino, Mario

“…Chronic kidney disease (CKD) is characterized by the retention of solutes named uremic toxins, which strongly associate with high morbidity and mortality…”
Get full text

The Key Role of Phosphate on Vascular Calcification by Cozzolino, Mario, Ciceri, Paola, Galassi, Andrea, Mangano, Michela, Carugo, Stefano, Capelli, Irene, Cianciolo, Giuseppe

“…Vascular calcification (VC) is common in dialysis and non-dialysis chronic kidney disease (CKD) patients, even in the early stage of the disease. For this…”
Get full text

The emerging role of iron in heart failure and vascular calcification in CKD by Ciceri, Paola, Cozzolino, Mario

“…Iron deficiency is a frequent comorbidity of cardiovascular (CV) diseases and nearly 50% of patients with heart failure (HF) with or without anaemia have low…”
Get full text

Vitamin K in Chronic Kidney Disease by Cozzolino, Mario, Mangano, Michela, Galassi, Andrea, Ciceri, Paola, Messa, Piergiorgio, Nigwekar, Sagar

“…Vitamin K is a composite term referring to a group of fat-soluble vitamins that function as a cofactor for the enzyme γ-glutamyl carboxylase (GGCX), which…”
Get full text

Serum PTH levels in dialysis: better safe than sorry by Cozzolino, Mario, Ciceri, Paola

Get full text

Effects of a medium cut-off (Theranova ® ) dialyser on haemodialysis patients: a prospective, cross-over study by Cozzolino, Mario, Magagnoli, Lorenza, Ciceri, Paola, Conte, Ferruccio, Galassi, Andrea

“…Despite significant advances in haemodialysis (HD) in recent decades, current dialysis techniques are limited by inadequate removal of uraemic solutes such as…”
Get full text

Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis by Ciceri, Paola, Elli, Francesca, Braidotti, Paola, Falleni, Monica, Tosi, Delfina, Bulfamante, Gaetano, Block, Geoffrey A, Cozzolino, Mario

“…Abstract Background and aims High phosphate-induced vascular calcification (VC) and iron deficiency-induced anemia are two major contributors of cardiovascular…”
Get full text

SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease by Podestà, Manuel Alfredo, Sabiu, Gianmarco, Galassi, Andrea, Ciceri, Paola, Cozzolino, Mario

“…Results from recent randomized controlled trials on inhibitors of the sodium-glucose cotransporter 2 (SGLT2) have determined a paradigm shift in the treatment…”
Get full text

Do we need new phosphate binders in dialysis? by Cozzolino, Mario, Galassi, Andrea, Ciceri, Paola

“…Patients affected by chronic kidney disease (CKD) have a greater risk of mortality than the general population. Fatal cardiovascular events are the most…”
Get full text

Current Therapy in CKD Patients Can Affect Vitamin K Status by Cozzolino, Mario, Cianciolo, Giuseppe, Podestà, Manuel Alfredo, Ciceri, Paola, Galassi, Andrea, Gasperoni, Lorenzo, Manna, Gaetano La

“…Chronic kidney disease (CKD) patients have a higher risk of cardiovascular (CVD) morbidity and mortality compared to the general population. The links between…”
Get full text

A new in vitro model to delay high phosphate-induced vascular calcification progression by Ciceri, Paola, Elli, Francesca, Cappelletti, Laura, Tosi, Delfina, Braidotti, Paola, Bulfamante, Gaetano, Cozzolino, Mario

“…An increasing amount of patients affected by advanced chronic kidney disease suffer from vascular calcification (VC) that associates with cardiovascular…”
Get full text

Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease by Ciceri, Paola, Bono, Valeria, Magagnoli, Lorenza, Sala, Matteo, d’Arminio Monforte, Antonella, Galassi, Andrea, Barassi, Alessandra, Marchetti, Giulia, Cozzolino, Mario

“…Chronic kidney disease (CKD) patients are more susceptible to infections compared to the general population. SARS-CoV-2 virus pathology is characterized by a…”
Get full text

Phosphate in Chronic Kidney Disease Progression by Cozzolino, Mario, Foque, Denis, Ciceri, Paola, Galassi, Andrea

“…A direct and independent association between serum phosphate (P) levels and mortality has been reported. High circulating P concentrations, still within the…”
Get more information

Efficacy and Safety of COVID-19 Vaccine in Patients on Renal Replacement Therapy by Frittoli, Michela, Cassia, Matthias, Barassi, Alessandra, Ciceri, Paola, Galassi, Andrea, Conte, Ferruccio, Cozzolino, Mario Gennaro

“…Patients with CKD on RRT are at high risk for severe disease and mortality in COVID-19 disease. We decided to conduct an observational prospective study to…”
Get full text

Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation by Leotta, Chiara, Hernandez, Leah, Tothova, Lubomira, Arefin, Samsul, Ciceri, Paola, Cozzolino, Mario Gennaro, Barany, Peter, Chromek, Milan, Stenvinkel, Peter, Kublickiene, Karolina

“…Circulating cell-free DNA (cfDNA) has diverse applications in oncological, prenatal, toxicological, cardiovascular, and autoimmune diseases, diagnostics, and…”
Get full text

Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19 by Galassi, Andrea, Ciceri, Paola, Bono, Valeria, Magagnoli, Lorenza, Sala, Matteo, Artioli, Luisa, Rovito, Roberta, Hadla, Mohamad, Yellenki, Vaibhav, D'Arminio Monforte, Antonella, Tincati, Camilla, Cozzolino, Mario, Marchetti, Giulia

“…A cytokine storm drives the pathogenesis of severe COVID-19 infection and several biomarkers have been linked to mortality. Chronic kidney disease (CKD)…”
Get full text

1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study by Galassi, Andrea, Fasulo, Eliana Maria, Ciceri, Paola, Casazza, Roberta, Bonelli, Fabrizio, Zierold, Claudia, Calleri, Mariella, Blocki, Frank A, Palmieri, Maria Assunta, Mastronardo, Claudio, Cozzolino, Mario G

“…Heterogeneous progression of chronic kidney disease (CKD) toward dialysis advocates improving in renal care management. Diagnosis and staging of CKD relies on…”
Get full text

Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism by Monciino, Paola, Magagnoli, Lorenza, Fasulo, Eliana, Frittoli, Michela, Leotta, Chiara, Pham, Hoang Nhat, Stucchi, Andrea, Ciceri, Paola, Galassi, Andrea, Cozzolino, Mario

“…Background. Secondary hyperparathyroidism (SHPT) is a major risk factor for cardiovascular events and all-cause mortality in hemodialysis (HD) patients. The…”
Get full text

Cardiovascular disease in dialysis patients by Cozzolino, Mario, Mangano, Michela, Stucchi, Andrea, Ciceri, Paola, Conte, Ferruccio, Galassi, Andrea

“…Cardiovascular disease (CVD) is a highly common complication and the first cause of death in patients with end-stage renal disease (ESRD) on haemodialysis…”
Get full text

Transforming the frail and elderly patient into an Iron Man: how to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease by Cozzolino, Mario, Ciceri, Paola

Get full text